Biosynthesis of the α-D-Mannosidase Inhibitor (-)-Swainsonine

Shaonan Liu,Zainab Batool,Yang Hai
DOI: https://doi.org/10.1101/2024.09.26.615303
2024-09-27
bioRxiv
Abstract:(-)-Swainsonine is a polyhydroxylated indolizidine alkaloid with potent inhibitory activity against α-D-mannosidases. In this work, we successfully reconstituted swainsonine biosynthetic pathway both in vivo and in vitro. Our study unveiled a surprising epimerization mechanism involving an imine reductase (SwnN) and two non-heme iron and α-ketoglutarate-dependent oxygenases (SwnH2 and SwnH1). SwnH2 is a multifunctional enzyme responsible for both C2-hydroxylation and amine desaturation, while SwnN completes the oxidation-reduction sequence to achieve the net redox neutral epimerization. Notably, SwnN exhibits substrate-dependent stereospecificity and the stereochemical outcome of SwnN-catalyzed iminium reduction is determined by SwnH1-catalyzed C8-hydroxylation. We also discovered that an O -acetyl ester can serve as a detachable protecting/directing group, altering the site-selectivity of SwnH2-catalyzed hydroxylation while maintaining the stereoselectivity. Insights gained from the biochemical characterization of these tailoring enzymes enabled biocatalytic synthesis of a new polyhydroxylated indolizidine alkaloid, opening doors to the biosynthesis of diverse natural product-based glycosidase inhibitors.
What problem does this paper attempt to address?